GSK2890457
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2890457, covering 2017-10-23 to 2017-10-23. Get the full timeline:
Most recent: Clinical Trial Update: To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes [Phase 2]